LLY
Price
$737.83
Change
+$2.64 (+0.36%)
Updated
Sep 3 closing price
Capitalization
661.43B
56 days until earnings call
MRK
Price
$84.18
Change
-$1.30 (-1.52%)
Updated
Sep 3 closing price
Capitalization
210.26B
56 days until earnings call
Interact to see
Advertisement

LLY vs MRK

Header iconLLY vs MRK Comparison
Open Charts LLY vs MRKBanner chart's image
Eli Lilly & Co
Price$737.83
Change+$2.64 (+0.36%)
Volume$2.22M
Capitalization661.43B
Merck & Co
Price$84.18
Change-$1.30 (-1.52%)
Volume$12.71M
Capitalization210.26B
LLY vs MRK Comparison Chart in %
Loading...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LLY vs. MRK commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a Buy and MRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (LLY: $737.83 vs. MRK: $84.18)
Brand notoriety: LLY and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LLY: 47% vs. MRK: 113%
Market capitalization -- LLY: $661.43B vs. MRK: $210.26B
LLY [@Pharmaceuticals: Major] is valued at $661.43B. MRK’s [@Pharmaceuticals: Major] market capitalization is $210.26B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $661.43B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LLY’s FA Score shows that 2 FA rating(s) are green whileMRK’s FA Score has 2 green FA rating(s).

  • LLY’s FA Score: 2 green, 3 red.
  • MRK’s FA Score: 2 green, 3 red.
According to our system of comparison, both LLY and MRK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LLY’s TA Score shows that 5 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).

  • LLY’s TA Score: 5 bullish, 3 bearish.
  • MRK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LLY is a better buy in the short-term than MRK.

Price Growth

LLY (@Pharmaceuticals: Major) experienced а +0.50% price change this week, while MRK (@Pharmaceuticals: Major) price change was +0.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.55%. For the same industry, the average monthly price growth was +1.88%, and the average quarterly price growth was +9.40%.

Reported Earning Dates

LLY is expected to report earnings on Oct 30, 2025.

MRK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.55% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($661B) has a higher market cap than MRK($210B). LLY has higher P/E ratio than MRK: LLY (48.22) vs MRK (12.97). LLY YTD gains are higher at: -3.854 vs. MRK (-13.794). MRK has less debt than LLY: MRK (35.4B) vs LLY (39.9B).
LLYMRKLLY / MRK
Capitalization661B210B315%
EBITDAN/A25B-
Gain YTD-3.854-13.79428%
P/E Ratio48.2212.97372%
RevenueN/A63.6B-
Total CashN/A8.62B-
Total Debt39.9B35.4B113%
FUNDAMENTALS RATINGS
LLY vs MRK: Fundamental Ratings
LLY
MRK
OUTLOOK RATING
1..100
1075
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
2574
SMR RATING
1..100
1427
PRICE GROWTH RATING
1..100
6356
P/E GROWTH RATING
1..100
9691
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (9) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (76). This means that MRK’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for MRK (74). This means that LLY’s stock grew somewhat faster than MRK’s over the last 12 months.

LLY's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as MRK (27). This means that LLY’s stock grew similarly to MRK’s over the last 12 months.

MRK's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as LLY (63). This means that MRK’s stock grew similarly to LLY’s over the last 12 months.

MRK's P/E Growth Rating (91) in the Pharmaceuticals Major industry is in the same range as LLY (96). This means that MRK’s stock grew similarly to LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LLYMRK
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
51%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
55%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 3 days ago
47%
Declines
ODDS (%)
Bearish Trend 8 days ago
53%
Bearish Trend 8 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTG.X0.5217580.033993
+6.97%
Bitcoin Gold cryptocurrency
VERA22.960.35
+1.55%
Vera Therapeutics
JBTM141.44-0.75
-0.53%
JBT Marel Corporation
AMRN15.04-0.14
-0.92%
Amarin Corp Plc
AI.X0.124187-0.001544
-1.23%
Sleepless AI cryptocurrency

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.36%
AZN - LLY
41%
Loosely correlated
+2.39%
BIIB - LLY
37%
Loosely correlated
+1.43%
OGN - LLY
35%
Loosely correlated
+4.35%
MRK - LLY
33%
Poorly correlated
-1.52%
PFE - LLY
31%
Poorly correlated
-0.76%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-1.52%
PFE - MRK
58%
Loosely correlated
-0.76%
BMY - MRK
50%
Loosely correlated
+0.19%
BIIB - MRK
50%
Loosely correlated
+1.43%
NVS - MRK
48%
Loosely correlated
+1.26%
AZN - MRK
46%
Loosely correlated
+2.39%
More